Abstract C25: The 16p13.3 genomic gain in prostate cancer: A role for PDK1 in disease progression
Khalil Choucair(The Barbara Ann Karmanos Cancer Institute), Jeremy A. Squire(Universidade de São Paulo), Ladan Fazli, Kanishka Sircar(McGill University), Fadi Brimo(McGill University Health Centre), Eleonora Scarlata(McGill University Health Centre), Joshua Ejdelman(McGill University Health Centre), Martin Gleave(University of British Columbia), Karl‐Philippe Guérard(McGill University Health Centre), Jacques Lapointe(Université Laval), Maisa Yoshimoto(University of Alberta), Isabela W. Cunha(AC Camargo Hospital), Armen Aprikian, Simone Chevalier
Cited by 0
Related Papers
The Molecular Taxonomy of Primary Prostate Cancer
|Cell|2015|3.3k
Management of Patients with Advanced Prostate Cancer: The Report of the Advanced Prostate Cancer Consensus Conference APCCC 2017
|European Urology|2017|644
Interstitial Cells of Cajal as Precursors of Gastrointestinal Stromal Tumors
|The American Journal of Surgical Pathology|1999|567
Circulating Tumor DNA Genomics Correlate with Resistance to Abiraterone and Enzalutamide in Prostate Cancer
|Cancer Discovery|2018|520
Antisense therapy for cancer
|Nature reviews. Cancer|2005|399